Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H22N2O3 |
| Molecular Weight | 266.3361 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(CN2CCNCC2)C(OC)=C1OC
InChI
InChIKey=UHWVSEOVJBQKBE-UHFFFAOYSA-N
InChI=1S/C14H22N2O3/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16/h4-5,15H,6-10H2,1-3H3
| Molecular Formula | C14H22N2O3 |
| Molecular Weight | 266.3361 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:18:33 UTC 2023
by
admin
on
Sat Dec 16 17:18:33 UTC 2023
|
| Record UNII |
N9A0A0R9S8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78322
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
629618
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
||
|
WHO-VATC |
QC01EB15
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
658318
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
642918
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
||
|
WHO-ATC |
C01EB15
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB09069
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
m11144
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
D014292
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
CHEMBL203266
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
N9A0A0R9S8
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
225-690-2
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
10826
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000076942
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
1544
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
SUB11306MIG
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
DTXSID2048531
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
5011-34-7
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
TRIMETAZIDINE
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
2750
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
C76590
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY | |||
|
21109
Created by
admin on Sat Dec 16 17:18:34 UTC 2023 , Edited by admin on Sat Dec 16 17:18:34 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
Improves myocardial glucose utilization through inhibition of fatty acid metabolism.
|
||
|
|
BINDER->LIGAND |
BINDING
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
